According to GlobalData’s medical device pipeline database, 125 Parasitology & Mycology devices are in various stages of development globally. GlobalData’s report Parasitology & Mycology provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 32 are in active development, while the remaining 95 are in an inactive stage of development. There are 13 products in the early stages of development, and the remaining 19 are in the late stages of development.
In Vitro Diagnostics (IVD) include reagents, instruments and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. Parasitology refers to the study of parasites, their hosts and relationship between them. This category comprises of antibodies, nucleic acid reagents and test kits used for detection for pathogenic protozoans. Mycology refers to study of fungi. This category comprises of immunoassays and nucleic acid reagents used to detect pathogenic fungi.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Parasitology & Mycology pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Parasitology & Mycology devices. Overall, most of these Parasitology & Mycology pipeline devices are being developed by private entities.
Key players involved in the active development of Parasitology & Mycology include Adaltis, Roche Diagnostics International, Johns Hopkins University, Qiagen, Genome Diagnostics, Microbiologics, SerImmune, T2 Biosystems, University of Georgia and Washington University in St Louis.
For a complete picture of the developmental pipeline for Parasitology & Mycology devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.